New Topical Formulation for Hair Loss Shows Promise

For some individuals, the emotional aspects of living with hair loss can be substantial and ultimately damage one’s self-esteem and lead to depression. Medical advancements made in recent decades have offered hope to millions of people that are affected, but not all patients experience results with the products currently available. One major reason for this is scalp hair loss is caused by a lot of different factors. Genetics, disease, hormonal changes, and aging are all possible contributors to an individual’s thinning hair.

New Polycystic Kidney Disease Treatment

Polycystic Kidney Disease (PKD) is the most frequently inherited kidney disorder and affects nearly 600,000 Americans and as many as 12 million people worldwide. Currently, there are no FDA approved treatments for PKD.

Researchers at the University of Kansas have created a novel compound and method for treating PKD that leads to the inhibition of cyst growth.


Polycystic Kidney Disease

Subscribe to RSS - drug-discovery

KU Today